---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-23-000216"
form_type: "8-K"
ticker: "STEX"
cik: "0001530766"
company_name: "Streamex Corp."
filed_at: "2023-03-16T23:59:59+00:00"
generated_at: "2026-06-18T00:28:29.175870+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# BioSig raises $1.72M in PIPE; sells shares and warrants to institutional investors

## Summary
- Sold 1,550,540 common shares at $1.10928/share plus warrants for 775,270 shares at $1.04678.
- Gross proceeds of $1,719,983 from the March PIPE.
- Warrants are exercisable 6 months after issuance, expiring 5.5 years from issuance date.
- Placement agent Laidlaw & Co. received a warrant for 67,611 shares as compensation.
- Offering exempt under Section 4(a)(2) and Regulation D of the Securities Act.

## SEC filing metadata
- accession: 0001185185-23-000216
- form_type: 8-K
- ticker: STEX
- cik: 0001530766
- company_name: Streamex Corp.
- filed_at: 2023-03-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1530766/000118518523000216/0001185185-23-000216-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1530766/000118518523000216/biosig20230314_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-23-000216
- JSON: https://secwatch.observer/filing/0001185185-23-000216.json
- Plain text: https://secwatch.observer/filing/0001185185-23-000216.txt

## Key facts
- Material Agreements
  Streamex Corp. entered into Securities Purchase Agreement with certain institutional and accredited investors valued at aggregate consideration of $1,719,983.01 (effective 2023-03-14).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain institutional and accredited investors
  - Value: aggregate consideration of $1,719,983.01
  - Effective: 2023-03-14
  source text: On March 14, 2023, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional and accredited investors (the “Investors”), pursuant to which the Company sold to the Investors an aggregate of 1,550,540 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a purchase price of $1.10928 per share, and warrants (the “Warrants”) to purchase up to 775,270 shares of Common Stock (the “Warrant Shares” and together with the Shares and Warrants, the “Securities”), at an exercise price of $1.04678 per share, that will become exercisable six months after the date of issuance and will expire five and one-half years following the date of issuance, in exchange for aggregate consideration of $1,719,983.01 (the “March PIPE”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1530766/000118518523000216/0001185185-23-000216-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.